← Analysis page  ·  Pieter Slegers hub  ·  Research hub

Actionable insights — ETF Portfolio Update: Just Buy The Haystack

Bound a trend by its own arithmetic, express each factor twice in two geographies, and publish the losing transactions.
2026-MAR-29 · Compounding Quality (Substack) · Pieter Slegers / TJ Terwilliger · read ↗ · full analysis · transcript
How to read this page: each insight is a method used in this issue, written so it can be rerun on any factor portfolio. Written post, so no timestamps.

1. Bound an extrapolated trend by its own arithmetic

The repeatable method
  1. Take the trend everyone is extrapolating and ask what it implies if continued indefinitely.
  2. Where the implication is impossible — a share of a total exceeding 100% — you have a hard ceiling, which is stronger than any forecast.
  3. Then check whether the trend has ever reversed historically, using rolling multi-year windows rather than a single long chart.
  4. Look for current evidence that the reversal has started, and separate that evidence from the ceiling argument.
Here: "The US outperformance can't go on forever. If it did, US stocks would eventually make up 100% of the global stock market" — supported by rolling five-year windows showing alternating leadership, and by 2025 returns of 36.4% (Europe), 32.7% (Asia) and 25.9% (EM) against 18.1% for the S&P 500.
Watch for

2. Express every factor twice — once per accessible jurisdiction

The repeatable method
  1. Write down the factors you want exposure to (here: quality, size, multifactor, emerging markets) before choosing any funds.
  2. For each factor, find both a US-listed fund and a UCITS equivalent, because "if you live in the US, you can't buy non-US ETFs. And if you live outside the US, you can't buy US ETFs."
  3. Keep the two books at similar weights so the pair is comparable.
  4. Match on the factor and the index methodology, not on the sponsor's name.
Here: equal-weight, wide moat, small cap, mid/multi-factor quality, emerging markets and minimum volatility all exist in both books — RSP/MOAT/VB/XMHQ/USMV against GOAT.AS/IUSN.DE/MVOL.L and the untickered UCITS lines.
Watch for

3. Use paired funds as a natural experiment on geography

The repeatable method
  1. Chart each factor's US and non-US expression side by side over the same period.
  2. Read the dispersion: a wide gap means the return came from geography, not from the factor.
  3. Use that to decide where to add — the same idea at a much lower price is available on one side of the pair.
  4. Set the honest expectation that the gap is not predictive: "over time, I expect both portfolios to generate similar returns."
Here: small cap ~+44% (US) vs ~+15% (global); min vol ~+1% vs ~+16%; mid-cap quality ~+8% vs world multifactor ~+29%; wide moat ~+19% vs ~+11%. Same factors, opposite outcomes depending on the listing.
Watch for

4. Publish the losing transactions, not just the aggregate return

The repeatable method
  1. Record every purchase with its date, price, quantity and current mark — not just the portfolio total.
  2. Show the negative lines with the same prominence as the positive ones.
  3. Revisit the reasoning given at the time of a losing purchase, so the process is reviewed rather than just the outcome.
  4. Report the portfolio CAGR alongside, so the individual lines can be seen in proportion.
Here: the February 2026 VB purchase at $277.32 is marked −7.60% six weeks later — the transaction the previous month's issue argued for on a "25-year-wide" small-cap valuation gap. The book: $9,528.99, 7.4% CAGR, seventeen purchases.
Watch for

5. Reduce a quality screen to three measurable inputs

The repeatable method
  1. Define quality by three things you can measure from filings: return on equity (profitability), earnings variability (predictability) and debt-to-equity (safety).
  2. Apply the screen mechanically to a broad universe rather than case by case.
  3. Then look at what it actually bought — the resulting top ten is the real definition of the screen.
  4. Judge the screen by whether that portfolio is one you would want, not by the elegance of the rules.
Here: IQLT on ROE, earnings variability and D/E — producing ASML at 5.97%, then Shell, Novartis, Allianz, Roche, AstraZeneca, Nestlé, ABB, Zurich and Schneider. A European large-cap, healthcare-heavy book with an oil major in second place.
Watch for

6. Let the schedule, not the scoreboard, choose the position to top up

The repeatable method
  1. Decide in advance whether monthly additions go to the target-weight gap, the worst performer, or the strongest conviction — and write the rule down.
  2. If the rule is weight-based, it will systematically add to laggards, which is the intended behaviour, not a mistake.
  3. State whether any given purchase is the rule executing or a judgment overriding it.
  4. Review annually whether the laggards recovered — that is the test of the rule, not of any single purchase.
Here: $500 into USMV, the American book's smallest (5.3%) and weakest (+1%) line, with no argument offered this month — compare July 2026, where the same purchase is justified on an explicit high-vol/low-vol spread.
Watch for

Methods distilled from the archived Compounding Quality post for personal study. Not investment advice.